Financials Instituto de Diagnóstico S.A.

Equities

INDISA

CL0000001587

Healthcare Facilities & Services

End-of-day quote Santiago S.E. 06:00:00 2024-05-05 pm EDT 5-day change 1st Jan Change
1,467 CLP 0.00% Intraday chart for Instituto de Diagnóstico S.A. -0.31% +16.17%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 311,738 240,991 210,620 225,488 226,813 178,009
Enterprise Value (EV) 1 347,190 282,060 258,874 300,688 325,444 277,275
P/E ratio 21.2 x 20.7 x 60.2 x 10.9 x 17.4 x 1,234 x
Yield 2.36% 1.93% 0.83% 4.58% 1.73% -
Capitalization / Revenue 2.14 x 1.6 x 1.51 x 1.2 x 1.19 x 0.81 x
EV / Revenue 2.39 x 1.88 x 1.86 x 1.59 x 1.7 x 1.27 x
EV / EBITDA 12.9 x 12.9 x 22.8 x 10.7 x 22.7 x 20.5 x
EV / FCF 24.8 x -301 x -48.7 x -15.6 x -21.5 x -686 x
FCF Yield 4.03% -0.33% -2.05% -6.43% -4.65% -0.15%
Price to Book 4.1 x 2.94 x 2.48 x 2.37 x 2.23 x 1.71 x
Nbr of stocks (in thousands) 140,930 140,930 140,930 140,930 140,930 140,930
Reference price 2 2,212 1,710 1,494 1,600 1,609 1,263
Announcement Date 3/22/19 3/27/20 3/24/21 3/23/22 3/23/23 3/28/24
1CLP in Million2CLP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 145,411 150,185 139,356 188,543 191,288 218,934
EBITDA 1 26,884 21,810 11,372 28,053 14,351 13,540
EBIT 1 20,896 15,577 5,431 22,369 13,312 3,796
Operating Margin 14.37% 10.37% 3.9% 11.86% 6.96% 1.73%
Earnings before Tax (EBT) 1 19,302 14,258 3,664 24,378 12,652 -2,581
Net income 1 14,695 11,630 3,501 20,650 13,050 144.3
Net margin 10.11% 7.74% 2.51% 10.95% 6.82% 0.07%
EPS 2 104.3 82.52 24.84 146.5 92.60 1.024
Free Cash Flow 1 13,993 -935.7 -5,319 -19,333 -15,121 -404.2
FCF margin 9.62% -0.62% -3.82% -10.25% -7.9% -0.18%
FCF Conversion (EBITDA) 52.05% - - - - -
FCF Conversion (Net income) 95.22% - - - - -
Dividend per Share 2 52.10 33.00 12.40 73.20 27.80 -
Announcement Date 3/22/19 3/27/20 3/24/21 3/23/22 3/23/23 3/28/24
1CLP in Million2CLP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2024
Net Debt -
Net Cash position -
Leverage (Debt/EBITDA) -
Free Cash Flow -
ROE (net income / shareholders' equity) 7.3%
ROA (Net income/ Total Assets) 2.8%
Assets -
Book Value Per Share -
Cash Flow per Share -
Capex -
Capex / Sales -
Announcement Date -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1,467 CLP
Average target price
1,900 CLP
Spread / Average Target
+29.48%
Consensus
  1. Stock Market
  2. Equities
  3. INDISA Stock
  4. Financials Instituto de Diagnóstico S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW